Details for New Drug Application (NDA): 213810
✉ Email this page to a colleague
The generic ingredient in SUCCINYLCHOLINE CHLORIDE is succinylcholine chloride. There are six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
Summary for 213810
Tradename: | SUCCINYLCHOLINE CHLORIDE |
Applicant: | Aspiro |
Ingredient: | succinylcholine chloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 213810
Physiological Effect | Neuromuscular Depolarizing Blockade |
Medical Subject Heading (MeSH) Categories for 213810
Suppliers and Packaging for NDA: 213810
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 213810 | ANDA | Henry Schein, Inc. | 0404-9983 | 0404-9983-20 | 1 VIAL, MULTI-DOSE in 1 BAG (0404-9983-20) / 10 mL in 1 VIAL, MULTI-DOSE |
SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 213810 | ANDA | Camber Pharmaceuticals, Inc. | 31722-981 | 31722-981-31 | 25 VIAL, MULTI-DOSE in 1 CARTON (31722-981-31) / 10 mL in 1 VIAL, MULTI-DOSE (31722-981-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML | ||||
Approval Date: | May 4, 2020 | TE: | AP | RLD: | No |
Complete Access Available with Subscription